Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
文摘

Resistance to antiangiogenic therapy involves metabolic symbiosis patterning in RCC

mTOR pathway mediates this resistance and mTOR inhibition blocks metabolic symbiosis

In patients, antiangiogenics induce symbiotic patterning mostly in resistant tumors

mTOR pathway implication is also suggested in patients treated with antiangiogenics

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.